BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, May 30, 2024
Breaking News: Try BioWorld for free for two weeks
See today's BioWorld Science
Home
» Kissei Pharmaceutical presents new orexin OX2 receptor agonists for narcolepsy
To read the full story,
subscribe
or
sign in
.
Neurology/psychiatric
Kissei Pharmaceutical presents new orexin OX2 receptor agonists for narcolepsy
May 8, 2024
No Comments
Kissei Pharmaceutical Co. Ltd. has divulged orexin OX2 receptor agonists reported to be useful for the treatment of narcolepsy.
BioWorld Science
Neurology/psychiatric
Patents